When will generic lurasidone be available?
A lurasidone generic launch date depends on the specific drug product strength/form (tablets vs. different milligram doses) and the outcome/timing of patent and regulatory exclusivity for that exact version. The exact date is not provided in the information available here, so a precise launch date can’t be confirmed from this data alone.
Does the launch date vary by strength or formulation?
Yes. Generic “lurasidone” can refer to multiple strengths and, in some cases, different release/formulation versions. Even when a company is cleared to market a generic, real-world availability can differ by strength because approvals and manufacturing scale-up can happen unevenly across presentations.
What filings or approvals determine the launch timing?
Generic availability is typically gated by FDA approval (often via an abbreviated pathway) plus any applicable patent protections and exclusivity periods covering the brand product and/or specific formulations. Those factors determine when an FDA-approved generic can be marketed.
How can I check the exact FDA market launch date for a specific lurasidone strength?
To get the most accurate date, look up the specific lurasidone generic product on FDA databases (or the label/approval record for that strength) and confirm:
- the exact strength (e.g., the milligram tablet size)
- the approved generic manufacturer
- the FDA approval date and whether the product has been marketed
If you tell me the brand name you mean (commonly Latuda) and the strength(s) (e.g., 20 mg, 40 mg, 60 mg, 80 mg), I can narrow the search intent to the correct product version and help you identify the relevant FDA approval/availability date.
What if the generic is approved but not yet on shelves?
It can take time after FDA approval for distributors and pharmacies to carry the product widely. So “approval date” and “widely available launch date” can differ.
Sources
None provided with your question, so I can’t cite a specific launch date from verified materials.